Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: Initial experiences

Korean Journal of Radiology

Volumn 12, Issue 2, 2011, Pages 176-186

  Lee, Jae Young ^a   Choi, Byung Ihn ^a   Ryu, Ji Kon ^a   Kim, Yong Tae ^a   Hwang, Joo Ha ^b   Kim, Se Hyung ^a   Han, Joon Koo ^a  

^a Seoul National University Hospital   (South Korea)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Gemcitabine; High intensity focused ultrasound ablation; Pancreatic cancer

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; OXALIPLATIN;

ABDOMINAL PAIN; ADULT; AGED; ANALGESIA; ARTICLE; BILIARY SEPSIS; BURN; CANCER CHEMOTHERAPY; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HAND FOOT SYNDROME; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; LEUKOPENIA; MALE; OVERALL SURVIVAL; PAIN; PANCREAS CANCER; PANCREATITIS; PROGNOSIS; SCLEROSIS; SEPSIS; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79952916370     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2011.12.2.176     Document Type: Article

References (18)

1. Kim YS, Rhim H, Choi MJ, Lim HK, Choi D. High-intensity focused ultrasound therapy: an overview for radiologists. Korean J Radiol 2008;9:291-302
2. Wu F, Wang ZB, Zhu H, Chen WZ, Zou JZ, Bai J, et al. Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology 2005;236:1034-1040
3. Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, et al. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol 2009;27:5513-5518
4. Herrmann R, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, Schuller J, et al. Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. J Clin Oncol 2007;25:2212-2217
5. Park JK, Ryu JK, Lee JK, Yoon WJ, Lee SH, Kim YT, et al. Gemcitabine chemotherapy versus 5-fluorouracilbased concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer. Pancreas 2006;33:397-402
6. Park BB, Park JO, Lee HR, Lee J, Choi DW, Choi SH, et al. A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma. Cancer Chemother Pharmacol 2007;60:489-494
7. Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol 2001;27:1099-1106
8. Li JJ, Gu MF, Luo GY, Liu LZ, Zhang R, Xu GL. Complications of high intensity focused ultrasound for patients with hepatocellular carcinoma. Technol Cancer Res Treat 2009;8:217-224
9. Li JJ, Xu GL, Gu MF, Luo GY, Rong Z, Wu PH, et al. Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors. World J Gastroenterol 2007;13:2747-2751
10. Dromi S, Frenkel V, Luk A, Traughber B, Angstadt M, Bur M, et al. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res 2007;13:2722-2727
11. Poff JA, Allen CT, Traughber B, Colunga A, Xie J, Chen Z, et al. Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib. Radiology 2008;248:485-491
12. Wang RS, Liu LX, Gu YH, Lin QF, Guo RH, Shu YQ. The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer. Biomed Pharmacother 2010;64:309-312
13. Zhao H, Yang G, Wang D, Yu X, Zhang Y, Zhu J, et al. Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. Anticancer Drugs 2010;21:447-452
14. Xiong LL, Hwang JH, Huang XB, Yao SS, He CJ, Ge XH, et al. Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP 2009;10:123-129
15. Hwang JH, Wang YN, Warren C, Upton MP, Starr F, Zhou Y, et al. Preclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumors. Ultrasound Med Biol 2009;35:967-975
16. White RR, Hurwitz HI, Morse MA, Lee C, Anscher MS, Paulson EK, et al. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol 2001;8:758-765
17. Wolff RA. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas: great logic, grim reality. Ann Surg Oncol 2001;8:747-748
18. Paparel P, Chapelon JY, Bissery A, Chesnais S, Curiel L, Gelet A. Influence of the docetaxel administration period (neoadjuvant or concomitant) in relation to HIFU treatment on the growth of Dunning tumors: results of a preliminary study. Prostate Cancer Prostatic Dis 2008;11:181-186